Hong Kong stocks slip after Moody’s cuts banks’ outlook, weak China trade data

[ad_1]

Hong Kong stocks approached a 13-month low as Chinese banks and insurers slipped after Moody’s lowered the outlook on several top industry players, in lockstep with its cut on the sovereign outlook. China’s import data surprisingly fell in November.

The Hang Seng Index retreated 0.7 per cent to 16,345.89 on Thursday, near the lowest since mid-November last year. The Tech Index also dropped 0.7 per cent and the Shanghai Composite Index declined 0.1 per cent.

China Life Insurance tumbled 1 per cent to HK$10.10 after Moody’s lowered its outlook to negative to reflect China’s slowdown risks. China Merchants Bank tumbled 2.6 per cent to HK$25.85. Other lenders including ICBC and Construction Bank erased a drop of nearly 1 per cent.

Bank stocks have suffered a beating since this year amid concerns Beijing is heaping pressure on them to help ease a liquidity crisis faced by weak developers, putting their asset quality at risk. Goldman Sachs downgraded ICBC, Agricultural Bank of China and Industrial Bank in July on dividend pressure.

Moody’s also lowerd Hong Kong’s outlook on Thursday, a day after lowering China’s A1 rating outlook to negative. Historically, about one-third of bond issuers suffered rating cuts within 18 months after their outlook turned negative, Moody’s said.

In Hong Kong, four firms get US$2.6 billion support to stem stocks rout

“China’s economy is still enduring a correction and it seems growth is unlikely to reaccelerate any time soon,” said Wu Kan, an analyst at Soochow Securities in Shanghai. “Sentiment is weak” going into the year-end, he added.

The Hang Seng Index has dropped 17 per cent this year, the worst performer among the world’s key benchmarks. The sell-offs have led to stock buy-back pledges from Meituan, WuXi Biologics and Swire Pacific to help stem the rot.

01:39

Chinese President Xi Jinping visits Shanghai in first post-Covid trip

Chinese President Xi Jinping visits Shanghai in first post-Covid trip

WuXi Biologics failed to sustain a rebound, losing 2.4 per cent to HK$29.95. Alibaba Group slid 0.6 per cent to HK$69.70 and Tencent lost 1.2 per cent to HK$307.80. PetroChina fell 2.2 per cent to HK$4.86 and CNOOC sank 2.7 per cent to HK$12.46 as crude oil futures dropped to a five-month low on demand concerns.

Meanwhile, China’s exports rose 0.5 per cent, halting a six-month contraction, the customs bureau said. Economists had expected zero-growth. Imports shrank 0.6 per cent versus forecast for a 3.9 per cent increase. Other reports to be released later this week may show consumer and producer prices fell again last month.

Other major Asian markets all fell. Japan’s Nikkei 225 slipped 1.8 per cent, while South Korea’s Kospi and Australia’s S&P/ASX 200 both lost 0.1 per cent.

[ad_2]

Source link